• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于局部阴道治疗的聚乙二醇化脂质体可改善干扰素α的递送。

PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha.

作者信息

Jøraholmen May Wenche, Basnet Purusotam, Acharya Ganesh, Škalko-Basnet Nataša

机构信息

Drug Transport and Delivery Research Group, Department of Pharmacy, Faculty of Health Sciences, University of Tromsø The Arctic University of Norway, Universitetsveien 57, 9037 Tromsø, Norway.

Women's Health and Perinatology Research Group, Department of Clinical Medicine, University of Tromsø The Arctic University of Norway, Universitetsveien 57, 9037 Tromsø, Norway; Department of Obstetrics and Gynecology, University Hospital of North Norway, Sykehusveien 5738, 9038 Tromsø, Norway.

出版信息

Eur J Pharm Biopharm. 2017 Apr;113:132-139. doi: 10.1016/j.ejpb.2016.12.029. Epub 2017 Jan 11.

DOI:10.1016/j.ejpb.2016.12.029
PMID:28087379
Abstract

Recent studies regarding mucosal drug delivery indicate that nanosystems with surface-available polyethylene glycol (PEG) are able to penetrate mucus barrier, assure closer contact with the epithelium, and improve drug delivery to vagina. In the present work, we developed the mucus-penetrating PEGylated liposomes containing interferon alpha-2b (IFN α-2b), destined to provide localized therapy for human papilloma virus (HPV) vaginal infections. The PEGylated liposomes were of a mean size of 181±8nm, bearing a negative zeta potential of - 13mV and an entrapment efficiency of 81±10%. In vitro release experiments on model membrane showed a nearly non-existent IFN α-2b release from both the control and liposomally-associated IFN α-2b. However, the ex vivo penetration studies performed on the vaginal tissue obtained from pregnant sheep, showed the clear elevated IFN α-2b penetration from PEGylated liposomes as compared to the control. Furthermore, mucin studies confirmed the absence of interaction between the PEG-modified liposomes and mucin, confirming their ability to penetrate mucus and reach the deeper epithelium. The system holds a promise in improving topical delivery of IFN α-2b through enhanced efficacy of local anti-viral therapy.

摘要

近期有关黏膜给药的研究表明,具有表面可利用聚乙二醇(PEG)的纳米系统能够穿透黏液屏障,确保与上皮细胞更紧密接触,并改善药物向阴道的递送。在本研究中,我们制备了含有干扰素α-2b(IFN α-2b)的可穿透黏液的聚乙二醇化脂质体,旨在为人乳头瘤病毒(HPV)阴道感染提供局部治疗。聚乙二醇化脂质体的平均粒径为181±8nm,ζ电位为 - 13mV,包封率为81±10%。在模型膜上进行的体外释放实验表明,对照品和脂质体结合的IFN α-2b几乎均无IFN α-2b释放。然而,对从怀孕绵羊获得的阴道组织进行的离体渗透研究表明,与对照相比,聚乙二醇化脂质体的IFN α-2b渗透明显增加。此外,黏蛋白研究证实聚乙二醇修饰的脂质体与黏蛋白之间不存在相互作用,证实了它们穿透黏液并到达更深层上皮细胞的能力。该系统有望通过增强局部抗病毒治疗的疗效来改善IFN α-2b的局部递送。

相似文献

1
PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha.用于局部阴道治疗的聚乙二醇化脂质体可改善干扰素α的递送。
Eur J Pharm Biopharm. 2017 Apr;113:132-139. doi: 10.1016/j.ejpb.2016.12.029. Epub 2017 Jan 11.
2
Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon alpha.聚乙二醇化蛋白包裹的多囊泡脂质体:一种持续释放α干扰素的新方法。
Drug Dev Ind Pharm. 2006 Jul;32(6):699-707. doi: 10.1080/03639040500528954.
3
Chitosan-coated liposomes for topical vaginal therapy: assuring localized drug effect.用于局部阴道治疗的壳聚糖包被脂质体:确保局部药物疗效。
Int J Pharm. 2014 Sep 10;472(1-2):94-101. doi: 10.1016/j.ijpharm.2014.06.016. Epub 2014 Jun 10.
4
Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.抗聚乙二醇抗体可改变高度聚乙二醇化纳米颗粒在黏液中的迁移率和生物分布。
Acta Biomater. 2016 Oct 1;43:61-70. doi: 10.1016/j.actbio.2016.07.019. Epub 2016 Jul 14.
5
[Interferon alpha-2b modified with polyethylene glycol].聚乙二醇修饰的干扰素α-2b
Sheng Wu Gong Cheng Xue Bao. 2008 Sep;24(9):1658-63.
6
A novel method to prepare highly encapsulated interferon-alpha-2b containing liposomes for intramuscular sustained release.一种制备用于肌肉内持续释放的高度包封的含干扰素-α-2b脂质体的新方法。
Eur J Pharm Biopharm. 2006 Aug;64(1):9-15. doi: 10.1016/j.ejpb.2006.03.003. Epub 2006 Jun 22.
7
Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system.利用新型聚乙二醇化脂质体包埋海藻酸钠支架系统经阴道递送 siRNA。
J Control Release. 2011 Nov 7;155(3):418-26. doi: 10.1016/j.jconrel.2011.02.002. Epub 2011 Feb 18.
8
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.比较聚乙二醇化干扰素α-2b与聚乙二醇化干扰素α-2a加利巴韦林治疗人类免疫缺陷病毒患者慢性丙型肝炎的随机试验。
Hepatology. 2009 Jan;49(1):22-31. doi: 10.1002/hep.22598.
9
Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin.急性丙型肝炎:聚乙二醇干扰素 α-2b 24 周疗程与聚乙二醇干扰素 α-2b 单独或联合利巴韦林 12 周疗程的比较。
Hepatology. 2014 Jun;59(6):2101-9. doi: 10.1002/hep.26991. Epub 2014 Apr 29.
10
Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.聚乙二醇化干扰素α-2b与利巴韦林治疗慢性丙型肝炎患者的药代动力学及增强的PKR反应
J Viral Hepat. 2007 Jun;14(6):396-403. doi: 10.1111/j.1365-2893.2006.00803.x.

引用本文的文献

1
Vaginal mycobiome characteristics and therapeutic strategies in vulvovaginal candidiasis (VVC): differentiating pathogenic species and microecological features for stratified treatment.外阴阴道念珠菌病(VVC)的阴道真菌微生物群特征及治疗策略:区分致病菌种和微生态特征以进行分层治疗。
Clin Microbiol Rev. 2025 Jun 12;38(2):e0028424. doi: 10.1128/cmr.00284-24. Epub 2025 Apr 22.
2
Navigating Latency-Inducing Viral Infections: Therapeutic Targeting and Nanoparticle Utilization.应对潜伏期诱导性病毒感染:治疗靶点与纳米颗粒的应用
Biomater Res. 2024 Oct 16;28:0078. doi: 10.34133/bmr.0078. eCollection 2024.
3
Hydrogel- and Nanocomposite-Based Drug-Delivery Strategies in the Treatment of Vaginal Infections.
基于水凝胶和纳米复合材料的药物递送策略在阴道感染治疗中的应用
Polymers (Basel). 2024 Mar 12;16(6):775. doi: 10.3390/polym16060775.
4
Encapsulation and release of hydrocortisone from proliposomes govern vaginal delivery.原封不动地从前体脂质体中释放氢化可的松可控制阴道输送。
Drug Deliv Transl Res. 2023 Apr;13(4):1022-1034. doi: 10.1007/s13346-022-01263-x. Epub 2022 Dec 30.
5
Toxicity Assessment of Resveratrol Liposomes-in-Hydrogel Delivery System by EpiVaginal Tissue Model.通过阴道上皮组织模型对白藜芦醇脂质体水凝胶递送系统进行毒性评估
Pharmaceutics. 2022 Jun 17;14(6):1295. doi: 10.3390/pharmaceutics14061295.
6
Stimuli-Responsive Polymers for Transdermal, Transmucosal and Ocular Drug Delivery.用于透皮、透粘膜和眼部给药的刺激响应性聚合物。
Pharmaceutics. 2021 Dec 1;13(12):2050. doi: 10.3390/pharmaceutics13122050.
7
Quality by Design for Optimizing a Novel Liposomal Jojoba Oil-Based Emulgel to Ameliorate the Anti-Inflammatory Effect of Brucine.基于质量源于设计理念优化新型脂质体荷荷巴油基乳凝胶以改善马钱子碱的抗炎作用
Gels. 2021 Nov 18;7(4):219. doi: 10.3390/gels7040219.
8
Forms and Methods for Interferon's Encapsulation.干扰素的包封形式与方法
Pharmaceutics. 2021 Sep 22;13(10):1533. doi: 10.3390/pharmaceutics13101533.
9
Recent Advances in Polymer-Based Vaginal Drug Delivery Systems.基于聚合物的阴道给药系统的最新进展
Pharmaceutics. 2021 Jun 15;13(6):884. doi: 10.3390/pharmaceutics13060884.
10
Characterization of Liposomes Using Quantitative Phase Microscopy (QPM).使用定量相显微镜(QPM)对脂质体进行表征。
Pharmaceutics. 2021 Apr 21;13(5):590. doi: 10.3390/pharmaceutics13050590.